Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Published on by Forensic Scientist

Ms. Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Central University of Punjab | India

Ms. Shivani Chib is an emerging researcher in the field of pharmacology, specializing in neurodegenerative diseases with a particular focus on Parkinson’s disease and the therapeutic potential of phytoconstituents. Currently pursuing her Ph.D. at the Central University of Punjab, Bathinda, she has contributed extensively through high-impact publications, innovative patents, international presentations, and active peer-reviewing for reputed journals. With multiple national and international awards, she stands out as a dedicated woman researcher committed to advancing pharmacological science and drug discovery.

Professional Profile

Scopus

Google Scholar

Education

Ms. Shivani Chib is currently pursuing her doctoral research in Pharmacology at the Central University of Punjab, Bathinda, under the guidance of Dr. Randhir Singh. Her Ph.D. research centers on Parkinson’s disease and the therapeutic potential of bioactive phytoconstituents, reflecting her dedication to translational research in neuropharmacology. Before her doctoral studies, she completed her Master of Pharmacy in Pharmacology from ISF College of Pharmacy, where she excelled academically and carried out research in experimental pharmacology. Her academic journey began with a Bachelor of Pharmacy in Pharmaceutical Sciences from Sri Sai College of Pharmacy. This progression in higher education reflects not only her intellectual growth but also her determination to specialize in pharmacology and contribute to the field of neuroscience.

Experience

Her professional journey as a researcher began during her postgraduate studies, where she worked as a Research Scholar and focused on understanding drug mechanisms and neuroprotective agents. Currently, as a Ph.D. Research Scholar at the Central University of Punjab, she is engaged in cutting-edge research on Parkinson’s disease, with particular emphasis on dopaminergic neuronal death and the role of phytochemicals such as luteolin and wogonin. She has also contributed as a reviewer for multiple Springer Nature journals, a role that reflects her expertise and recognition in the scientific community. Her active engagement in national and international conferences, combined with her innovative experimental approaches, illustrates her wide-ranging experience in both research and academic settings.

Research Interest

Her research interests revolve around neuropharmacology, neurodegenerative disorders, natural product-based drug discovery, and cognitive impairments associated with aging. She has a deep focus on elucidating the mechanisms of dopaminergic neuronal death in Parkinson’s disease and identifying bioactive phytoconstituents like luteolin and wogonin as potential therapeutic agents. Additionally, her work extends to exploring CNS toxicity of chemotherapeutics, marine functional foods, metabolic syndromes, and the cross-talk between central nervous and cardiovascular systems.

Awards and Recognitions

Ms. Shivani Chib has received numerous awards and recognitions throughout her career, including Best Working Model Award, Best Poster Awards at national and international conferences, and the prestigious GPAT fellowship. She has been awarded multiple international travel grants, including from the Movement Disorder Society and the Anusandhan National Research Foundation, enabling her to present her work globally, including at conferences in the USA and Japan. She has also received certificates of excellence in peer reviewing from Springer Nature and BP International. Her innovation in neuroscience is further highlighted by her registered patents on novel laboratory apparatuses, reflecting her inventive approach to experimental pharmacology.

Publications

Ms. Shivani Chib has published widely in reputed international journals, with her contributions cited in several scholarly works. Selected publications include:

Title: Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs
Journal: Ageing Research Reviews
Published on: 2024
Citation: 49

Title: Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases
Journal: Neurotoxicology and Teratology
Published on: 2022
Citation: 35

Title: Unlocking the therapeutic potential of natural stilbene: exploring pterostilbene as a powerful ally against aging and cognitive decline
Journal: Ageing Research Reviews
Published on: 2023
Citation: 21

Title: Treatment of diabetic complications: do flavonoids holds the keys?
Journal: Critical Reviews in Food Science and Nutrition
Published on: 2024
Citation: 16

Title: Paradigms and success stories of natural products in drug discovery against neurodegenerative disorders (NDDs)
Journal: Current Neuropharmacology
Published on: 2024
Citation: 15

Title: Microbiota-brain-gut-Axis relevance to Parkinson’s disease: potential therapeutic effects of probiotics
Journal: Current Pharmaceutical Design
Published on: 2022
Citation: 11

Title: Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease
Journal: Phytotherapy Research
Published on: 2025
Citation: 10

Conclusion

Ms. Shivani Chib has established herself as a promising woman researcher in pharmacology through her strong academic background, impactful publications, innovative patents, and global recognitions. Her work in exploring the therapeutic applications of phytoconstituents against neurodegenerative disorders has the potential to open new pathways for safer and more effective treatments. With her commitment to excellence, interdisciplinary approach, and growing global presence, she exemplifies the qualities of a future leader in pharmacological sciences. She is therefore highly deserving of the Women Researcher Award, which would further empower her to continue contributing to scientific progress and global healthcare solutions.

Mohamad Taleuzzaman | Pharmacology | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Mohamad Taleuzzaman | Pharmacology | Best Researcher Award

Maulana Azad University | India

Dr. Mohamad Taleuzzaman is a distinguished academician and researcher in the field of pharmaceutical chemistry. With a career spanning over 15 years, he has contributed significantly to pharmaceutical education, research, and administration. Currently serving as a Professor and Head of the Department at Maulana Azad University, Jodhpur, his expertise lies in pharmaceutical analysis, drug development, and bioanalytical research. Passionate about scientific innovation, he has played a vital role in mentoring students and advancing pharmaceutical sciences.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Contributions – Dr. Taleuzzaman has numerous publications in high-impact journals, showcasing his active engagement in research.

  • Diverse Research Interests – His work spans pharmaceutical chemistry, nanotechnology, molecular docking, and bioanalytical method development.

  • Academic Leadership – Serving as a Professor and HOD, he has contributed to institutional development and research coordination.

  • Patent Holder – His patent on a polymeric nano scaffold for anti-diabetic applications highlights his innovation.

  • Mentorship – He has successfully guided Ph.D. and M.Pharm students, contributing to academic growth.

  • Strong Administrative Experience – Coordinating academic inspections, examinations, and regulatory compliance.

Education 🎓

Dr. Taleuzzaman pursued his Ph.D. in Pharmaceutical Chemistry from Glocal University, Saharanpur, in 2018. He completed his M.Pharm in Pharmaceutical Analysis from Jamia Hamdard, New Delhi, securing a first-class distinction with 73.84% in 2007. His academic journey began with a B.Pharm from the same institution in 2005. Additionally, he qualified for the GATE examination in 2005 with an impressive percentile of 92.49, further solidifying his strong foundation in pharmaceutical sciences.

Professional Experience 💼

With over 15 years of professional experience, Dr. Taleuzzaman has held key positions in both academia and the pharmaceutical industry. Since 2019, he has been serving as a Professor and HOD at Maulana Azad University, Jodhpur. Prior to this, he worked as an Associate Professor at Glocal School of Pharmacy, Saharanpur, and as an Assistant Professor at KIET School of Pharmacy, Ghaziabad. His industrial experience includes roles such as Product Development Manager at Ultra Biolabs Pvt. Ltd., Chandigarh, and Quality Officer at Ali & Abdul Karim Trading Co., Oman.

Research Interests On Pharmacology 📚

Dr. Taleuzzaman’s research is centered on pharmaceutical analysis, drug formulation, and bioanalytical method development. His Ph.D. research focused on the extraction, characterization, and quantification of thymoquinone and eugenol from Nigella sativa and Myristica fragrans. He has also explored novel drug delivery systems, nanotechnology applications in pharmaceuticals, and synthetic methodologies for bioactive compounds.

Awards & Recognitions 🏆

Dr. Taleuzzaman has been recognized for his contributions to pharmaceutical sciences and academic excellence. His innovative research has led to a patent titled “Sitagliptin loaded polymeric nano scaffold for enhanced anti-diabetic performance” (Patent number: 2021104076). He has also been actively involved in coordinating major academic accreditations such as PCI, UGC, and NAAC inspections at leading pharmacy institutions.

Publications 📄

Dr. Taleuzzaman has published extensively in high-impact journals. Some of his notable research articles include:

  • Ultra performance liquid chromatography (UPLC)-a review
    Authors: M Taleuzzaman, S Ali, SJ Gilani, SS Imam, A Hafeez
    Year: 2015
    Citations: 133

  • Limit of blank (LOB), limit of detection (LOD), and limit of quantification (LOQ)
    Author: M Taleuzzaman
    Year: 2018
    Citations: 88

  • Eugenol as a potential drug candidate: A review
    Authors: M Taleuzzaman, P Jain, R Verma, Z Iqbal, MA Mirza
    Year: 2021
    Citations: 79

  • Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity
    Authors: M Bin-Jumah, SJ Gilani, MA Jahangir, A Zafar, S Alshehri, M Yasir, C Kala, …
    Year: 2020
    Citations: 70

  • Quality by design (Qbd) assisted development of phytosomal gel of aloe vera extract for topical delivery
    Authors: P Jain, M Taleuzzaman, C Kala, D Kumar Gupta, A Ali, M Aslam
    Year: 2021
    Citations: 48

  • Nano phytomedicine based delivery system for CNS disease
    Authors: MA Jahangir, C Anand, A Muheem, SJ Gilani, M Taleuzzaman, A Zafar, …
    Year: 2020
    Citations: 44

  • Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
    Authors: I Rahat, SS Imam, M Rizwanullah, S Alshehri, M Asif, C Kala, …
    Year: 2021
    Citations: 36

  • Benzothiazole incorporated thiazolidin-4-ones and azetidin-2-ones derivatives: Synthesis and in vitro antimicrobial evaluation
    Authors: SJ Gilani, K Nagarajan, SP Dixit, M Taleuzzaman, SA Khan
    Year: 2016
    Citations: 30

  • Phytosomal gel of Manjistha extract (MJE) formulated and optimized with central composite design of Quality by Design (QbD)
    Authors: M Taleuzzaman, A Sartaj, D Kumar Gupta, SJ Gilani, MA Mirza
    Year: 2023
    Citations: 29

  • Formulation and evaluation of thymoquinone niosomes: Application of developed and validated RP-HPLC method in delivery system
    Authors: SJ Gilani, SS Imam, A Ahmed, S Chauhan, MA Mirza, M Taleuzzaman
    Year: 2019
    Citations: 28

Conclusion 🔗

Dr. Mohamad Taleuzzaman’s dedication to pharmaceutical research and education has made a profound impact on the field. His work in drug development, bioanalytical chemistry, and nanotechnology has contributed to the advancement of pharmaceutical sciences. As a mentor, researcher, and academic leader, he continues to inspire and shape the future of pharmaceutical research.

Arvind Kumar Patel | Pharmacology | Best Researcher Award

Published on by Forensic Scientist

Dr. Arvind Kumar Patel | Pharmacology | Best Researcher Award

Narayan Institute of Pharmacy, Gopal Narayan Singh University | Bihar, India

Dr. Arvind Kumar Patel is a dedicated academician and researcher in the field of Pharmacology. With a strong commitment to education and research, he has made significant contributions to the pharmaceutical sciences. His expertise lies in pharmacological studies, toxicology, and herbal medicine research, aiming to enhance therapeutic approaches for various ailments. His passion for teaching and research continues to inspire students and professionals alike.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Research Contributions:
    • Published multiple research and review papers in reputed journals, including Scopus and Web of Science indexed journals.
    • Focused research on pharmacology, particularly on allergic conjunctivitis, toxicology, and phytopharmaceuticals, showcasing expertise in niche areas of pharmacology.
  2. Academic and Professional Excellence:
    • Earned a Ph.D. in Pharmacology with a robust academic background.
    • Currently serving as an Assistant Professor, contributing to the field through teaching and mentoring.
    • Experience in multiple institutions, enriching his teaching and research acumen.
  3. Innovative Research and Publications:
    • Contributed book chapters and authored a book on Pharmacology aligned with the PCI syllabus.
    • Presented research findings at various international and national conferences, demonstrating active participation in scientific discussions.
  4. Technical Proficiency:
    • Skilled in pharmacological screening, drug formulation processes, and animal handling.
    • Well-versed in research methodologies, experimental design, and analytical techniques.
  5. Awards and Recognitions:
    • Received awards such as Best Student of the Year and 1st prize in poster presentations, showcasing his dedication and competence.
    • Honored with titles such as “Mr. Perfect,” reflecting his well-rounded personality.

Education 🎓

Dr. Patel pursued his Ph.D. in Pharmacy from IFTM University, Moradabad, India, in 2023. He completed his M. Pharm in Pharmacology from the same university in 2017, securing an impressive 83.50%. His foundational education in pharmacy was obtained from Ashoka Institute of Technology & Management, Varanasi, where he earned his B. Pharm degree in 2015. His academic journey was rooted in a strong foundation laid at Mahabodhi Inter College, Varanasi.

Experience 🌟

Dr. Patel is currently serving as an Assistant Professor at Narayan Institute of Pharmacy, Gopal Narayan Singh University, Bihar, since June 2024. Previously, he gained valuable teaching experience at Baba Baijnath College of Pharmacy, Azamgarh, for two years and at Apex Institute of Pharmacy, Mirzapur, for five years. His vast teaching experience has equipped him with deep insights into pharmaceutical sciences and student mentorship.

Research Interest On Pharmacology 📚

His research interests revolve around pharmacological screening, herbal medicine, and drug toxicity studies. His notable research includes investigations into the anti-allergic conjunctivitis effects of medicinal plants and toxicity studies of plant extracts. His work aims to bridge the gap between traditional medicine and modern pharmacological advancements.

Awards & Achievements 🏆

Dr. Patel has received multiple accolades for his contributions to pharmaceutical sciences, including:

  • 1st Prize in Poster Presentation at ABHYUDAY (2014), Annual Fest of Ashoka Institute of Technology & Management.
  • Best Student of the Year (2015) at Ashoka Institute of Technology & Management.
  • Honored as Mr. Perfect (2015) in his farewell event.

Publications 📝

Dr. Patel has authored several research papers, review articles, and book chapters in reputed journals and publishing platforms. Some of his notable publications include:

  • Title: Thermodynamic life cycle assessment of humans with considering food habits and energy intake
    Authors: AK Patel, SPS Rajput
    Year: 2020
    Citations: 10

  • Title: Effects of nanofluid flow in micro channel heat sink for forced convection cooling of electronics device: a numerical simulation
    Authors: AK Patel, S Bhuvad, SPS Rajput
    Year: 2019
    Citations: 10

  • Title: Design and heat transfer performance analysis of mini-channel heat sink with water, EG and EG20 based nanofluids-computational approach
    Authors: AK Patel, SPS Rajput, R Kumar, A Sharma, AP Singh, MK Sharma, …
    Year: 2022
    Citations: 9

  • Title: Numerical analysis of micro-channel heat sink using ethylene glycol based nanofluid in case of electronics cooling
    Authors: SS Bhuvad, AK Patel, SPS Rajput
    Year: 2020
    Citations: 3

  • Title: Parametric Analysis of Energy and Exergy of the human body in Indian conditions
    Authors: SP Arvind Kumar Patel
    Year: 2020
    Citations: 2

  • Title: A review on human biological material-types, uses, storage and disposal
    Authors: AK Patel, SPS Rajput
    Year: 2019
    Citations: 2

  • Title: CFD Analysis for Heat Transfer Enhancement of Microchannels Heat Sink Using Nanofluid Flow in Case of Electronics Device
    Authors: SS Bhuvad, AK Patel, SPS Rajput
    Year: 2020
    Citations: 1

  • Title: Entropy production and Human life cycle assessment for Indians with considering protein, fat, and carbohydrate
    Authors: SP Arvind Kumar Patel
    Year: 2020

  • Title: Simulation of Natural Draft wet cooling tower with variation of Air inlet height through Computational Fluid Dynamics
    Authors: AS Arvind Kumar Patel
    Year: 2013

Conclusion 📝

Dr. Arvind Kumar Patel is a committed educator, researcher, and pharmacologist with a deep passion for advancing the field of pharmaceutical sciences. His contributions to research and academia continue to benefit students and professionals, furthering innovations in herbal pharmacology and drug toxicity studies. Through his dedication and expertise, he aspires to make a lasting impact in the domain of pharmacy and healthcare.

Shanbo Ma | Pharmacology | Best Researcher Award

Published on by Forensic Scientist

Dr. Shanbo Ma | Pharmacology | Best Researcher Award

Deputy Chief Pharmacist | Xijing Hospital of Air Force Medical University | China

Shanbo Ma is a dedicated researcher in the field of Chinese pharmacology, focusing on the pharmacological mechanisms and therapeutic potential of traditional Chinese medicine (TCM). With a strong academic background and extensive research experience, he has contributed significantly to the study of anti-inflammatory effects and active ingredients in TCM. His expertise spans molecular biology, cell biology, and bioinformatics, making him a key figure in integrating computational and experimental approaches to drug discovery.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Research Output & Impact 📚

    • Published multiple peer-reviewed articles in high-impact journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, and Journal of Biomolecular Structure & Dynamics.
    • Research spans diverse pharmacological applications, including colorectal cancer, anxiety treatment, ulcerative colitis, and depression, indicating a broad impact in Chinese pharmacology and molecular medicine.
    • Co-first and co-corresponding authorships in multiple papers highlight leadership in research projects.

  • Interdisciplinary Expertise 🔬

    • Skilled in network pharmacology, molecular docking, bioinformatics, and experimental validation, demonstrating a strong foundation in both computational and experimental pharmacology.
    • Expertise in cell biology, molecular biology, and animal experiments, which are critical for translational research in pharmacology.

  • Technical & Analytical Proficiency 💻

    • Proficient in essential research tools, including GraphPad, Cytoscape, Photoshop, SYBYL, and Image J, supporting advanced data analysis and visualization.

  • Recognition & Awards 🏆

    • Received the Outstanding Paper Award (2023) from the Chinese Pharmaceutical Society, a significant achievement showcasing research excellence.

  • Educational Background & Training 🎓

    • Holds a Ph.D. in Science of Chinese Pharmacology from Northwest University (2020–2024).
    • Completed a Master’s in Chinese Medicine from Shaanxi University of Chinese Medicine and a Bachelor’s in Pharmacology from Bengbu Medical University, providing a solid academic foundation.

🎓 Education

  • 📌 2020.09 – 2024.06 | Northwest University | Doctorate in Science of Chinese Pharmacology
  • 📌 2014.09 – 2017.07 | Shaanxi University of Chinese Medicine | Master’s in Chinese Medicine
  • 📌 2013.09 – 2017.07 | Bengbu Medical University | Bachelor’s in Pharmacology

💼 Experience

Shanbo Ma has been actively involved in pharmacological research, specializing in the bioactivity screening and mechanistic exploration of TCM. His work integrates network pharmacology, bioinformatics, and molecular docking techniques to elucidate drug mechanisms. He has also demonstrated proficiency in project design and team coordination, leading multiple research initiatives and collaborations.

🔬 Research Interests On Pharmacology

  •  Screening the pharmacological substance basis of traditional Chinese medicine
  •  Investigating the anti-inflammatory effects and mechanisms of TCM and its active ingredients
  •  Utilizing bioinformatics and network pharmacology to analyze drug-target interactions
  •  Exploring molecular docking and experimental validation methods for TCM efficacy

🏆 Awards

  • 🏅 Outstanding Paper Award, Chinese Pharmaceutical Society (2023)

📚 Publications

  • Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation

    • Authors: Ma Shanbo, Guo Xiaodi, et al.
    • Publication Year: 2024

  • Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways

    • Authors: Ma Shanbo, Chong Ye, et al.
    • Publication Year: 2024

  • Virtual screening-molecular docking-activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis

    • Authors: Ma Shanbo, Liu Lun, et al.
    • Publication Year: 2023

  • Investigating the mechanism of Sinisan formula in depression treatment: a comprehensive analysis using GEO datasets, network pharmacology, and molecular docking

    • Authors: Zheng Meiling, Yang, Shi Xiaopeng#, Ma Shanbo#
    • Publication Year: 2024

  • Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy

    • Authors: Guo Xiaodi, Wang Feiyan, Ma Shanbo#, Shi Xiaopeng#
    • Publication Year: 2023

  • Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics

    • Authors: Wang Jin*, Ma Shanbo*, et al.
    • Publication Year: 2022

🔬 Skills

  •  Expertise in cell biology, molecular biology, and animal experiments
  •  Proficient in bioinformatics tools such as GraphPad, AI, Photoshop, ImageJ, Cytoscape, and SYBYL
  •  Strong ability to design projects independently and coordinate teamwork

🔚 Conclusion

Shanbo Ma is a passionate and accomplished researcher in Chinese pharmacology, making substantial contributions to understanding the therapeutic mechanisms of traditional medicines. His expertise in network pharmacology, molecular docking, and bioinformatics enhances his ability to uncover novel insights in drug discovery. With numerous publications and an award-winning research portfolio, he continues to drive advancements in the field of traditional medicine research.

Mellar Davis | Pharmacology | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Mellar Davis | Pharmacology | Best Researcher Award

MD FCCP FAAHPM | Levine Cancer Institute | United States

Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.

Profile👤

Scopus

Strengths for the Awards✨

  • Extensive Research and Publications 📚

    • Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
    • Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
    • Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.

  • Significant Impact in Palliative Medicine 🌿

    • Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
    • Developed guidelines and educational programs for pain and opioid management in cancer care.
    • Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).

  • Recognized Excellence in Teaching and Mentorship 🎓

    • Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
    • Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.

  • Leadership and Professional Influence 🌍

    • Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
    • Co-Chair of the International Conference on Opioids, advancing pain research.

Education🎓

Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.

Experience👩‍⚕️

Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine

Research Interests On Pharmacology

📝 Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.

Awards and Honors🏆

Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.

Publications📚

  1. Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics

    • Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
    • Publication Year: 2025

  2. Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits

    • Authors: M.P. Davis
    • Publication Year: 2025

  3. Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study

    • Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
    • Publication Year: 2024

  4. Respiratory Depression Associated with Opioids: A Narrative Review

    • Authors: M.P. Davis, S.L. DiScala, A. Davis
    • Publication Year: 2024

  5. The Surprise Question: Not Ready for Prime Time

    • Authors: M.P. Davis
    • Publication Year: 2024

  6. Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline

    • Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
    • Publication Year: 2024

  7. Understanding The Number Needed to Treat

    • Authors: M.P. Davis, E.A. Vanenkevort
    • Publication Year: 2024

  8. Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline

    • Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
    • Publication Year: 2024

  9. Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia

    • Authors: M.P. Davis
    • Publication Year: 2024

Conclusion🎯

Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.

Mei-Lang Kung | Pharmacology | Women Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Mei-Lang Kung | Pharmacology | Women Researcher Award

Senior Assistant Research Fellow | Kaohsiung Veterans General Hospital | Taiwan

Dr. Mei-Lang Kung is a distinguished researcher and academic specializing in cancer biology, gene engineering, and phytochemical pharmacology. She currently serves as a Senior Assistant Research Fellow at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital, and an Assistant Professor at Shu-Zen Junior College of Medicine and Management. With a strong background in molecular biology and nanomedicine, Dr. Kung has contributed significantly to innovative research in oncology and nanomaterials for medical applications.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background 📚

    • Dr. Mei-Lang Kung holds a Ph.D. in Biological Science from National Sun Yat-sen University (2012).
    • Her dissertation focused on cancer cell migration and epithelial-mesenchymal transition, a highly relevant area in biomedical research.

  • Extensive Research Expertise 🔬

    • Her work spans multiple interdisciplinary fields, including cancer biology, gene engineering, phytochemical pharmacology, and green nanomaterials.
    • These diverse skill sets enhance the impact of her research in translational medicine.

  • Significant Research Contributions 🏆

    • 21+ peer-reviewed publications in high-impact journals (SCI-indexed).
    • Notable research on nanomedicine and cancer treatment strategies, contributing to innovative therapeutic approaches.
    • Demonstrated leadership as a corresponding author in multiple studies, reflecting independent research capability.

  • Recognition & Awards 🥇

    • Best Poster Award (2021) from the Taiwan Urology Association.
    • National Taiwan University System Young Scholars Award (2018) for innovative research.
    • Multiple Outstanding Paper Awards at prestigious conferences (IEEE, New Advance in Medicine, etc.).
    • These accolades highlight her excellence in research and scholarly impact.

Education 🎓

Dr. Kung earned her Ph.D. in Biological Science from National Sun Yat-sen University, Kaohsiung, Taiwan, in 2012, under the guidance of Prof. Tai Ming-Hong. Her dissertation focused on the mechanisms of hepatoma-derived growth factor-mediated cell migration and epithelial-mesenchymal transition. She also holds an M.S. in Biochemistry from Kaohsiung Medical University (2002) and a B.S. in Nutrition from Chung Shan Medical University (2000).

Experience 🌟

Dr. Kung has extensive experience in academia and research. Since 2019, she has been a Senior Assistant Research Fellow at Kaohsiung Veterans General Hospital. She also holds a faculty position at Shu-Zen Junior College of Medicine and Management. Previously, she served as an Assistant Faculty member (2017-2019) and a Postdoctoral Research Associate (2012-2017) in the Chemistry Department of National Sun Yat-sen University, working under Dr. Shuchen Hsieh.

Research Interests On Pharmacology 📚

Dr. Kung’s research interests include cancer biology, gene engineering, phytochemical pharmacology, and toxicology. She is particularly focused on the development and applications of green nanomaterials for cancer treatment. Her work explores novel phytochemically derived nanoparticles and their effects on cancer cell adhesion, proliferation, and metastasis.

Awards 🏆

  • 2021: Taiwan Urology Association “Best Academic Activity Award – Best Poster Award”
  • 2018: National Taiwan University System Young Scholars Selection for Innovative Research and Development Achievements – Excellent Work Award
  • 2015: New Advance in Generation Medicine, Cancer and Stem Cell Outstanding Paper Award
  • 2013: IEEE Nanotechnology Materials and Devices Conference, Outstanding Paper Award

Publications 📰

Dr. Kung has authored numerous peer-reviewed publications in high-impact journals. Below are some of her notable works:

  1. Wang, J.-H., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2025). “Nanosized ginger-derived phenolic zingerone obstructs cell cycle G2/M progression and initiates apoptosis in human colorectal cancer.” Environmental Toxicology. DOI:10.1002/tox.24470 (SCI; 2023 IF=4.4)
  2. Chu, L.-W., Chen, J.-Y., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2024). “Phytoconstituent-derived zingerone nanoparticles disrupt cell adhesion and suppress cell motility in melanoma B16F10 cells.” Journal of Biotechnology. DOI:10.1016/j.jbiotec.2024.06.015
  3. Kung, M.-L., Cheng, S. M., Wang, Y.-H., et al.* (2024). “Deficiency of RNA adenosine deaminase (ADAR2) ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in male diet-induced obese mice.” Communications Biology. (SCI; 2022 IF=5.9)
  4. Kung, M.-L., Yang, T.-H., Lin, C.-C., et al.* (2024). “ADAR2 deficiency ameliorates nonalcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.” Journal of Cachexia, Sarcopenia and Muscle. DOI:10.1002/jcsm.13460 (SCI; 2022 IF=8.9)
  5. Hu, T.-H., Wu, J.-C., Huang, S.-T., et al.* (2023). “HDGF Stimulates Liver Tumorigenesis by Enhancing Reactive Oxygen Species Generation in Mitochondria.” Journal of Biological Chemistry. (SCI; 2022 IF=4.8)

Conclusion 📚

Dr. Mei-Lang Kung has made remarkable contributions to cancer research and nanomedicine, with a strong emphasis on translating scientific discoveries into therapeutic applications. Her expertise in molecular oncology and green nanotechnology continues to impact the scientific community, making her a leader in the field of biomedical research. Through her innovative work, she strives to advance cancer treatment strategies and improve patient outcomes.

latifa khattabi | Pharmacology | Best Researcher Award

Published on by Forensic Scientist

Dr. latifa khattabi | Pharmacology | Best Researcher Award

senior researcher | National Biotechnology Research Center | Algeria

Dr. Latifa Khattabi is a passionate and accomplished Permanent Researcher at the Biotechnology Research Center (CRBt) in Constantine, Algeria. Born on November 3, 1990, in El Khroub, Constantine, she has dedicated her career to the field of molecular and cellular immunology. Known for her excellence, perseverance, and ambition, Dr. Khattabi has contributed significantly to the advancement of scientific research, particularly in antioxidant, anti-inflammatory, and pharmacological studies.

Profile

Orcid

Strengths for the Awards

  • Academic Excellence:
    • Achieved a PhD in “Molecular and Cellular Immunology” (2023) and was recognized as an “Excellent Student” during her undergraduate and master’s studies.
    • Comprehensive education in immunology, oncology, and biochemistry demonstrates strong foundational expertise.
  • Diverse Research Contributions:
    • Published over 22 scientific articles, including as a principal author, in high-impact journals.
    • Research spans across immunology, biochemistry, molecular biology, and toxicology.
    • Significant contributions to topics such as SARS-CoV-2, antioxidant activities, enzyme inhibition, and therapeutic plant derivatives.
  • Research Skills and Expertise:
    • Hands-on experience in advanced techniques, including ELISA, LC-MS/MS, PCR, molecular docking, in vitro and in vivo experiments, and bioinformatics.
    • Multidisciplinary approach integrating immunology, pharmacology, and analytical chemistry.
  • Professional Experience:
    • Over a decade of research at the Biotechnology Research Center (CRBT), where she contributed to innovative projects like camelid antibodies for tuberculosis.
    • Collaborated in projects involving antioxidants, anti-Alzheimer, anti-inflammatory, and antidiabetic activities, reflecting real-world applicability of her research.

Education 🎓

Dr. Khattabi has an impressive academic journey:

  • 2023: PhD in Molecular and Cellular Immunology from University Mentouri Constantine – UMC1.
  • 2013: Master’s Degree in Molecular and Cellular Immunology/Oncology from UMC1, graduating as an excellent student with a dissertation on thyroid cancer.
  • 2011: Bachelor’s Degree in Molecular and Cellular Immunology, also with distinction from UMC1.
  • 2008: Achieved her Baccalaureate in Experimental Sciences.

Experience 🌟

Dr. Khattabi has been a dedicated researcher at CRBt since 2014, excelling in areas such as:

  • Antioxidant, enzymatic, and toxicological assays for pharmacological studies.
  • Molecular biology techniques, including DNA extraction, PCR, and LC-MS/MS analysis.
  • In vivo experiments on animal models, focusing on toxicity and therapeutic effects.
    She is also well-versed in laboratory standards, biosafety protocols, and quality assurance.

Research Interests On Pharmacology 🔬

Her primary research interests include:

  1. Molecular immunology and its applications in oncology.
  2. Pharmacological evaluations, including antioxidant and anti-inflammatory mechanisms.
  3. The toxicological effects of pesticides on health and possible natural remedies.
  4. Epidemiological studies related to cancer and chronic diseases.
  5. Development of rapid diagnostic tools for infectious diseases like SARS-CoV-2.

Awards 🏆

Dr. Khattabi has been recognized for her outstanding contributions:

  • Awarded the Certificate of Excellent Student during her bachelor’s and master’s studies.
  • Nominee for various awards in the field of biotechnology and scientific innovation.

Publications 📚

  • Hydroxyphenylamine Phosphonate Derivatives
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: Journal of Molecular Structure
    • DOI: 10.1016/j.molstruc.2020.129121
    • Citations: Indexed, but specific count not provided​
  • Distribution of Leukocyte Subpopulation Among Students Threatened by Failure
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: International Journal of Research in Pharmaceutical Sciences
    • Citations: Not explicitly listed​
  • Recombinant Protein Targeting and Opsonizing Spike Glycoprotein for Enhancing SARS-CoV-2 Phagocytosis
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: Medical Hypotheses
    • DOI: 10.1016/j.mehy.2020.110108
    • Citations: Indexed but count unavailable​
  • Monomeric and Dimeric Copper (II) Complexes
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: Inorganica Chimica Acta
    • DOI: 10.1016/j.ica.2020.119519
    • Citations: Not specified​
  • Chemical Characterization and Antioxidant Potential of Rosmarinus Tournefortii
    • Authors: Khattabi L., et al.
    • Publication Year: 2019
    • Journal: Journal of Food Measurement and Characterization
    • DOI: 10.1007/s11694-019-00309-y
    • Citations: Not explicitly mentioned​

Conclusion 📝

Dr. Latifa Khattabi stands out as a prolific researcher, dedicated to tackling some of the most pressing challenges in molecular immunology and pharmacology. Her dedication, versatility, and collaborative spirit have cemented her position as a key contributor to the scientific community, both in Algeria and internationally.

Muneeb Ullah | Pharmacology | Best Researcher Award

Published on by Forensic Scientist

Mr. Muneeb Ullah | Pharmacology | Best Researcher Award

PhD | University, Busan | South Korea

Muneeb Ullah, a dedicated research assistant in the Department of Pharmacy at Pusan National University in Busan, South Korea, focuses on advancing therapeutic applications of nanotechnology in wound healing. With a strong foundation in Pharmaceutical Sciences from Pakistan, he specializes in innovative nanoparticle-based drug delivery for complex medical conditions, including diabetic and infected wounds.

Profile

 Scopus

Strengths for the Award

  • Academic and Research Background:
    • Muneeb holds advanced degrees in Pharmacy and Pharmaceutical Nanotechnology, with an MPhil focusing on nanoparticle drug delivery systems. This is complemented by hands-on experience as a Research Assistant at reputable institutions, including the Department of Pharmacy at Pusan National University in South Korea.
  • Research Impact and Publications:
    • With over 20 publications, an h-index and i10-index of 8 each, and a total citation count of 296, Muneeb demonstrates substantial academic influence in his field. His publications span high-impact journals and cover areas like wound healing, cancer therapy, and cardiovascular disease management, indicating a commitment to impactful, multidisciplinary research.
    • The research focus on novel therapeutics and nanotechnology is timely and relevant, especially in addressing global health issues like diabetes, wound healing, and cardiovascular diseases.
  • Awards and Recognition:
    • Recognition through awards such as the Higher Education Commission (HEC) Scholarship, Prime Minister Laptop Award, and Best Teacher Award highlight his commitment to academic excellence and education.
  • Technical and Laboratory Skills:
    • Proficiency in advanced laboratory techniques (e.g., nanoparticle preparation, HPLC, cell culturing) and analytical tools (e.g., Endnote, BioRender) positions Muneeb as a well-rounded researcher with essential technical skills.

Education 📚

Muneeb holds an MPhil in Pharmaceutical Sciences with a focus on Nanotechnology from Kohat University of Science and Technology (KUST), Pakistan. He graduated with a first division, gaining deep expertise in pharmaceutics, pharmacology, and biochemistry. His academic journey began with his F.Sc in Pre-Medical and continued with a BS in Pharmacy, both completed with high distinctions. He also possesses specialized skills in advanced research methodologies and analytical techniques.

Experience 💼

Currently, Muneeb serves as a Research Assistant at Pusan National University, contributing to nanoparticle preparation and its applications in wound healing. Previously, he taught at Billitong Higher Secondary School and worked as a Research Assistant at the National University of Medical Sciences, Islamabad. His professional background blends both academia and research, enhancing his practical understanding of nanotechnology in pharmaceutical sciences.

Research Interests 🔬

Muneeb’s primary research interests encompass Pharmaceutical Nanotechnology, with a specific focus on nanoparticle applications in wound healing, biofilm-associated infections, and oncology. His work investigates innovative drug delivery systems and explores novel therapies for diabetes-related wound healing and other complex diseases.

Awards 🏆

Muneeb has been recognized with several prestigious awards, including the HEC-Indigenous Scholarship for his undergraduate studies and the Best Talent Award as part of the Prime Minister’s Laptop Scheme in Pakistan (2018). He was also awarded the Best Teacher Award at Billitong Higher Secondary School in 2020, highlighting his commitment to academic excellence.

Publications 📄

  • Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease
    • Authors: Safdar, M.; Ullah, M.; Hamayun, S.; Mustopa, A.Z.; Hasan, N.
    • Year: 2024
    • Citations: 1
  • Development of Clindamycin-Releasing Polyvinyl Alcohol Hydrogel with Self-Healing Property for the Effective Treatment of Biofilm-Infected Wounds
    • Authors: Alifah, N.; Palungan, J.; Ardayanti, K.; Yoo, J.-W.; Hasan, N.
    • Year: 2024
    • Citations: 0
  • 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease
    • Authors: Khan, M.A.; Khan, N.; Ullah, M.; Naeem, M.; Hasan, N.
    • Year: 2024
    • Citations: 4
  • Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease
    • Authors: Ullah, A.; Ullah, M.; Lim, S.I.
    • Year: 2024
    • Citations: 7
  • Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications
    • Authors: Khan, S.U.; Ullah, M.; Saeed, S.; Khan, M.A.; Lu, K.
    • Year: 2024
    • Citations: 4
  • Single-cell RNA Sequencing (scRNA-seq): Advances and Challenges for Cardiovascular Diseases (CVDs)
    • Authors: Khan, S.U.; Huang, Y.; Ali, H.; Ullah, M.; Lu, K.
    • Year: 2024
    • Citations: 7
  • A review of recent advances in nanotechnology for the delivery of therapeutics in wound healing
    • Authors: Ullah, A.; Ullah, M.; Lee, G.-J.; Lim, S.I.
    • Year: 2024
    • Citations: 0
  • Nutrition and Dietary Intervention in Cancer: Gaps, Challenges, and Future Perspectives
    • Authors: Zeb, F.; Mehreen, A.; Naqeeb, H.; Haider, A.; Naeem, M.
    • Year: 2024
    • Citations: 0
  • Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease
    • Authors: Safdar, M.; Ullah, M.; Wahab, A.; Awan, U.A.; Naeem, M.
    • Year: 2024
    • Citations: 7
  • Shaping the Future of Cardiovascular Disease by 3D Printing Applications in Stent Technology and its Clinical Outcomes
    • Authors: Ullah, M.; Bibi, A.; Wahab, A.; Saeed, S.; Hussain, T.
    • Year: 2024
    • Citations: 18

Conclusion 📝

With a robust academic background, hands-on research experience, and a strong publication record, Muneeb Ullah is a promising researcher in the field of pharmaceutical nanotechnology. His work not only advances wound healing therapies but also contributes to the broader understanding of drug delivery innovations. He is well-positioned to make impactful contributions to healthcare and nanomedicine in the years to come.